Comparing Lanreotide vs Somatuline Depot
| Lanreotide | Somatuline Depot |
|
|---|
| Lanreotide | Somatuline Depot (lanreotide) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neuroendocrine Carcinoma, Carcinoid Syndrome, Acromegaly. lanreotide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neuroendocrine Carcinoma, Carcinoid Syndrome, Acromegaly. Somatuline Depot may also be used for purposes not listed in this medication guide. |
Related suggestions Neuroendocrine Carcinoma
Popular comparisons
|
|||||||
| More about Lanreotide | More about Somatuline Depot (lanreotide) | ||||||||
| Generic Status | |||||||||
| Ratings & Reviews | |||||||||
|
Lanreotide has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Somatuline Depot has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Drug Class | |||||||||
| Side Effects | |||||||||
|
Commonly reported side effects include:
See also: lanreotide side effects in more detail. |
Common side effects include:
See also: Somatuline Depot side effects in more detail. |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Somatuline Depot prices and generic prices |
||||||||
| Dosage Form(s) Available | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Somatuline Depot |
N/A |
||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
|
720 hours |
720 hours |
||||||||
| CSA Schedule ** View glossary of terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 145 drugs are known to interact with lanreotide:
|
A total of 145 drugs are known to interact with Somatuline Depot:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
N/A |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient resources | |||||||||
|
N/A |
|||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.